Literature DB >> 6295261

Direct and specific inactivation of rhinovirus by chalcone Ro 09-0410.

H Ishitsuka, Y T Ninomiya, C Ohsawa, M Fujiu, Y Suhara.   

Abstract

Studies of various analogs related to the antipicornavirus agent, 4',5-dihydroxy-3,3',7-trimethoxyflavone (Ro 09-0179), led to the identification of 4'-ethoxy-2'-hydroxy-4,6'-dimethoxychalcone (Ro 09-0410), a new and different type of antiviral agent. Ro 09-0410 had a high activity against rhinoviruses but no activity against other picornaviruses. Of 53 rhinovirus serotypes so far tested, 46 were susceptible to Ro 09-0410 in HeLa cell cultures. The concentration of Ro 09-0410 inhibiting 50% of the types of rhinovirus was about 0.03 micrograms/ml, whereas the 50% cytotoxic concentration was 30 microgram/ml. Ro 09-0410 inactivated rhinoviruses in direct dose-, time-, and temperature-dependent fashion. Since infectivity, reduced by exposure to the agent, completely regained the original level by extraction of the agent with chloroform, the inactivation may be associated with the binding of the agent to some specific site of the rhinovirus capsid.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6295261      PMCID: PMC183802          DOI: 10.1128/AAC.22.4.617

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Recovery of new viruses (coryzavirus) from cases of common cold in human adults.

Authors:  V V HAMPARIAN; A KETLER; M R HILLEMAN
Journal:  Proc Soc Exp Biol Med       Date:  1961-11

2.  Properties of poliovirus propagated in medium containing cesium chloride: implications for picornaviral structure.

Authors:  J E Mapoles; J W Anderegg; R R Rueckert
Journal:  Virology       Date:  1978-10-01       Impact factor: 3.616

3.  Investigation of the structure of polio- and human rhinovirions through the use of selective chemical reactivity.

Authors:  K Lonberg-Holm; B E Butterworth
Journal:  Virology       Date:  1976-05       Impact factor: 3.616

4.  A physico-chemical sub-grouping of the mammalian picornaviruses.

Authors:  J F Newman; D J Rowlands; F Brown
Journal:  J Gen Virol       Date:  1973-02       Impact factor: 3.891

5.  Acid liability of rhinovirus type 14: effect of pH, time, and temperature.

Authors:  J H Hughes; D C Thomas; V V Hamparian; H G Cramblett
Journal:  Proc Soc Exp Biol Med       Date:  1973-11

6.  Antipicornavirus flavone Ro 09-0179.

Authors:  H Ishitsuka; C Ohsawa; T Ohiwa; I Umeda; Y Suhara
Journal:  Antimicrob Agents Chemother       Date:  1982-10       Impact factor: 5.191

  6 in total
  24 in total

1.  Synthesis and anti-histaminic activity of some novel pyrimidines.

Authors:  Sk A Rahaman; Y Rajendra Pasad; Phani Kumar; Bharath Kumar
Journal:  Saudi Pharm J       Date:  2009-07       Impact factor: 4.330

2.  Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity.

Authors:  K Andries; B Dewindt; J Snoeks; L Wouters; H Moereels; P J Lewi; P A Janssen
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

3.  Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization.

Authors:  K Andries; B Dewindt; J Snoeks; R Willebrords
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

4.  Comparative studies on the modes of action of the antirhinovirus agents Ro 09-0410, Ro 09-0179, RMI-15,731, 4',6-dichloroflavan, and enviroxime.

Authors:  Y Ninomiya; M Aoyama; I Umeda; Y Suhara; H Ishitsuka
Journal:  Antimicrob Agents Chemother       Date:  1985-04       Impact factor: 5.191

Review 5.  Chemotherapy of rhinovirus colds.

Authors:  S J Sperber; F G Hayden
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

6.  Discrepancy between infectivity and antigenicity stabilization of oral poliovirus vaccine by a capsid-binding compound.

Authors:  K Andries; B Rombaut; B Dewindt; A Boeyé
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

7.  Poliovirus infection and expression of the poliovirus protein 2B provoke the disassembly of the Golgi complex, the organelle target for the antipoliovirus drug Ro-090179.

Authors:  I V Sandoval; L Carrasco
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Antirhinovirus compound 44,081 R.P. inhibits virus uncoating.

Authors:  B Alarcon; A Zerial; C Dupiol; L Carrasco
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

9.  Thermal inactivation of oral polio vaccine: contribution of RNA and protein inactivation.

Authors:  B Rombaut; B Verheyden; K Andries; A Boeyé
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

10.  Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles.

Authors:  M J Almela; M E González; L Carrasco
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.